F.D.A. Clears New Cancer-Fighting Drug From Roche

.

F.D.A. Clears New Cancer-Fighting Drug From Roche

A new drug from the drug company Roche has been given the nod by the US Food and Drug Administration (FDA) to improve the treatment of patients suffering from a kind of cancer of the blood and bone marrow.

Roche is calling the new medicine Gazyva which is meant to fight chronic lymphocytic leukemia along with added treatment with chemotherapy. It is meant for those patients who have never before been treated for the same.

Gazyva provides relief in this cancer by destroying cancer cells and enabling the natural immune system of the body to fight against them.

The FDA gave its approval to Gazyva after proof that the drug along with chemotherapy was a better treatment to chemotherapy alone in slowing the progress of the cancer cells.

It was also seen that cancer patients who got treatment from Gazyva combined with chemotherapy had a higher survival rate with 23 months before death, relapse or spreading of the cancer cells.

Earlier treatments treated only with chemotherapy only got 11.1 months.

The new drug Gazyva will be sold by Roche s Genentech unit.


Latest News

Alzheimer’s, dementia to affect 3 in 10 former NFL players
Fight against Ebola is long
HSBC to Pay $550 Million in Mortgage Case Settlement
Critical Review and Suggestions for Improvement Come Olive Garden’s Way from Inv
Breast cancer is not caused by bras
World record for boob job attempted by Gold Coast clinic
Brain keeps learning even when you are sleeping
Memory can be affected by your blood type
Female Baboons with Male Friends live Longer: Study
People keeping Bees as a Hobby
Many Senior Americans Still Struggle to Repay Student Loan
Increase in Wholesale Inventories Remain Meagre